Healthy volunteers needed to test two versions of an experimental drug
NCT ID NCT07565597
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This study looks at how two different versions of the experimental drug gecacitinib hydrochloride are absorbed and processed by the body. About 64 healthy adults aged 18 to 45 will take a single dose of each version under fasting conditions. The goal is to compare the drug levels in the blood to see if the two forms work the same way.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Third Hospital of Changsha
Changsha, Hunan, China
Conditions
Explore the condition pages connected to this study.